LNCaP, a high AR-expressing androgen responsive prostate cancer cell line, and PC3, a low AR-expressing androgen-independent prostate cancer cell line, were respectively used as positive and negative controls for DHT-stimulated cell proliferation. This evidence concerns the gene AR and prostate cancer.